nystatin

nystatin is a lipid of Polyketides (PK) class. Nystatin is associated with abnormalities such as Virus Diseases, Infection, Candidiasis, Leukopenia and Mycoses. The involved functions are known as Membrane Potentials, Uptake, Flow or discharge, Cell membrane potential and adenine transport. Nystatin often locates in Cell Wall, Plasma membrane, Extracellular, Membrane and Virion. The associated genes with nystatin are Genome, Integral Membrane Proteins, Amino Acids, Basic, P4HTM gene and Homologous Gene. The related lipids are Sterols, Liposomes, Membrane Lipids, Sphingolipids and 1,2-oleoylphosphatidylcholine. The related experimental models are Knock-out and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of nystatin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with nystatin?

nystatin is suspected in Infection, Mycoses, Candidiasis, Renal tubular disorder, Systemic mycosis, Invagination and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with nystatin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Diarrhea D003967 32 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Dermatitis, Occupational D009783 12 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Per page 10 20 50 100 | Total 126

PubChem Associated disorders and diseases

What pathways are associated with nystatin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with nystatin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with nystatin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with nystatin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with nystatin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with nystatin?

Knock-out

Knock-out are used in the study 'Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast.' (Gerstein AC et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways.' (Chen Y et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with nystatin

Download all related citations
Per page 10 20 50 100 | Total 3045
Authors Title Published Journal PubMed Link
Aitken-Saavedra J et al. Diversity, frequency and antifungal resistance of Candida species in patients with type 2 diabetes mellitus. 2018 Acta Odontol. Scand. pmid:30045641
Nagai N et al. Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles. 2018 Int J Mol Sci pmid:30041452
Monti D et al. Influence of a Combination of Chemical Enhancers and Iontophoresis on In Vitro Transungual Permeation of Nystatin. 2018 AAPS PharmSciTech pmid:29484614
Lotan AM et al. Topical Nystatin Treatment for Candida Infection Following Wound Reconstruction. 2018 Wounds pmid:29481329
Scheibler E et al. Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans. 2018 Arch. Oral Biol. pmid:29477025
Neppelenbroek KH et al. Effect of Incorporation of Antifungal Agents on the Ultimate Tensile Strength of Temporary Soft Denture Liners. 2018 J Prosthodont pmid:29135059
Wu SC et al. Hyaluronan size alters chondrogenesis of adipose-derived stem cells via the CD44/ERK/SOX-9 pathway. 2018 Acta Biomater pmid:29128538
Bouallegui Y et al. Effect of exposure time, particle size and uptake pathways in immune cell lysosomal cytotoxicity of mussels exposed to silver nanoparticles. 2018 Drug Chem Toxicol pmid:28583008
Kim HJ et al. Antifungal Effect of a Dental Tissue Conditioner Containing Nystatin-Loaded Alginate Microparticles. 2018 J Nanosci Nanotechnol pmid:29448504
Yang JS et al. Vibrio cholerae OmpU induces IL-8 expression in human intestinal epithelial cells. 2018 Mol. Immunol. pmid:29145158
Anwar A et al. Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole. 2018 Parasitol. Res. pmid:29218442
Dawgul MA et al. Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates. 2018 Med Chem pmid:29485003
Atai Z et al. In vivo study of antifungal effects of low-molecular-weight chitosan against Candida albicans. 2017 J Oral Sci pmid:28904319
Russo A et al. Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation. 2017 Mycoses pmid:28877374
Scheibler E et al. Use of nystatin and chlorhexidine in oral medicine: Properties, indications and pitfalls with focus on geriatric patients. 2017 Gerodontology pmid:28556195
Hotta J et al. Intraoral Device for Optimal Antifungal Delivery in a Rat Model. 2017 Curr Drug Deliv pmid:27739378
Kim HJ et al. Redesign of antifungal polyene glycosylation: engineered biosynthesis of disaccharide-modified NPP. 2017 Appl. Microbiol. Biotechnol. pmid:28488115
Honsho M et al. Plasmalogen biosynthesis is spatiotemporally regulated by sensing plasmalogens in the inner leaflet of plasma membranes. 2017 Sci Rep pmid:28272479
Gadd GM New horizons in geomycology. 2017 Environ Microbiol Rep pmid:27701824
Qiu Y et al. From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery. 2017 Mol. Pharm. pmid:29121767
Walmsley S et al. Engineered biosynthesis and characterisation of disaccharide-modified 8-deoxyamphoteronolides. 2017 Appl. Microbiol. Biotechnol. pmid:27858138
Rajendran K et al. Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri. 2017 ACS Chem Neurosci pmid:29206032
Dos Santos AG et al. The molecular mechanism of Nystatin action is dependent on the membrane biophysical properties and lipid composition. 2017 Phys Chem Chem Phys pmid:29098221
Kinoshita H et al. Anti-Rhodotorula activity of mycophenolic acid enhanced in the presence of polyene antibiotic nystatin. 2017 Lett. Appl. Microbiol. pmid:27801509
Tang H et al. Effect of inhibitors of endocytosis and NF-kB signal pathway on folate-conjugated nanoparticle endocytosis by rat Kupffer cells. 2017 Int J Nanomedicine pmid:29075112
Won HJ et al. Improved recovery and biological activities of an engineered polyene NPP analogue in Pseudonocardia autotrophica. 2017 J. Ind. Microbiol. Biotechnol. pmid:28555391
Kaufman DA et al. Congenital Cutaneous Candidiasis: Prompt Systemic Treatment Is Associated With Improved Outcomes in Neonates. 2017 Clin. Infect. Dis. pmid:28158439
Ono J et al. Widespread Genetic Incompatibilities between First-Step Mutations during Parallel Adaptation of Saccharomyces cerevisiae to a Common Environment. 2017 PLoS Biol. pmid:28114370
Vural A et al. The Effect of Nystatin Solution on Otoacoustic Emissions in Rats. 2017 J Int Adv Otol pmid:27819649
Zhang D et al. Residual detection of buparvaquone, nystatin, and etomidate in animal-derived food products in a single chromatographic run using liquid chromatography-tandem mass spectrometry. 2017 Food Chem pmid:28763970
Kunz D et al. Receptor mediated endocytosis of vicilin in Callosobruchus maculatus (Coleoptera: Chrysomelidae) larval midgut epithelial cells. 2017 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:28630013
Wheat CM et al. Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams. 2017 J. Pediatr. pmid:28438376
Sharifzadeh A et al. Synergistic anticandidal activity of menthol in combination with itraconazole and nystatin against clinical Candida glabrata and Candida krusei isolates. 2017 Microb. Pathog. pmid:28431915
Lee JH et al. Lineage-Specific Differentiation Is Influenced by State of Human Pluripotency. 2017 Cell Rep pmid:28380358
Sardi JC et al. Unexplored endemic fruit species from Brazil: Antibiofilm properties, insights into mode of action, and systemic toxicity of four Eugenia spp. 2017 Microb. Pathog. pmid:28259673
Girotra P et al. Identification of multi-targeted anti-migraine potential of nystatin and development of its brain targeted chitosan nanoformulation. 2017 Int. J. Biol. Macromol. pmid:28041915
Mohammadi G et al. Preparation, Physicochemical Characterization and Anti-fungal Evaluation of Nystatin-Loaded PLGA-Glucosamine Nanoparticles. 2017 Pharm. Res. pmid:27928646
Hellfritzsch M et al. Topical Antimycotics for Oral Candidiasis in Warfarin Users. 2017 Basic Clin. Pharmacol. Toxicol. pmid:27901310
Peixoto LR et al. Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp. 2017 Arch. Oral Biol. pmid:27771586
Mukherjee PK et al. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. 2017 AIDS pmid:27677161
Silva FC et al. Nystatin and lidocaine pastilles for the local treatment of oral mucositis. 2017 Pharm Dev Technol pmid:27499389
Lima JF et al. Porosity of temporary denture soft liners containing antifungal agents. 2016 Sep-Oct J Appl Oral Sci pmid:27812615
Torres KA et al. Activity of the aqueous extract of Schinus terebinthifolius Raddi on strains of the Candida genus. 2016 Rev Bras Ginecol Obstet pmid:28038478
Zemljič Jokhadar Š et al. Osmotic Effects Induced by Pore-Forming Agent Nystatin: From Lipid Vesicles to the Cell. 2016 PLoS ONE pmid:27788169
Konecna A et al. ERG6 gene deletion modifies Kluyveromyces lactis susceptibility to various growth inhibitors. 2016 Yeast pmid:27668979
Vega F et al. Concomitant sensitization to inhaled budesonide and oral nystatin presenting as allergic contact stomatitis and systemic allergic contact dermatitis. 2016 Cutis pmid:26919353
Graziano S et al. The global effect of exposing bakers' yeast to 5-fluoruracil and nystatin; a view to Toxichip. 2016 Chemosphere pmid:26694798
Kantarcioglu AS et al. Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole. 2016 Mycopathologia pmid:26442855
Kinoshita H et al. Cryptic antifungal compounds active by synergism with polyene antibiotics. 2016 J. Biosci. Bioeng. pmid:26323525
Ellepola AN et al. Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates. 2016 J Investig Clin Dent pmid:25388637